A carregar...
Regulation of sclerostin expression in multiple myeloma by Dkk-1; a potential therapeutic strategy for myeloma bone disease
Sclerostin is a potent inhibitor of osteoblastogenesis. Interestingly, newly diagnosed multiple myeloma (MM) patients have high levels of circulating sclerostin that correlate with disease stage and fractures. However, the source and impact of sclerostin in MM remains to be defined. Our goal was to...
Na minha lista:
| Publicado no: | J Bone Miner Res |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5002355/ https://ncbi.nlm.nih.gov/pubmed/26763740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2789 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|